medigraphic.com
SPANISH

Revista Mexicana de Urología

Organo Oficial de la Sociedad Mexicana de Urología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2010, Number 1

<< Back Next >>

Rev Mex Urol 2010; 70 (1)

Tamsulosin as adjuvant treatment for increasing calculus-free state after extracorporeal shock wave lithotripsy (ESWL) in nephro- and pyelolithiasis

Aguilar-Moreno JA, Maldonado-Ávila A, Garduño-Arteaga L, Castell-Cancino R, Jaspeasen-Gastélum J, Virgen-Gutiérrez F
Full text How to cite this article

Language: Spanish
References: 8
Page: 11-14
PDF size: 576.48 Kb.


Key words:

tamsulosin, extracorporeal shock wave lithotripsy.

ABSTRACT

Background: Through the utilization of both extracorporeal shock wave lithotripsy (ESWL) and medical expulsive therapy a calculus-free state can be achieved in a single procedure and at low cost to the patient. In this context, medical expulsive therapy plays an important adjuvant role following ESWL.
Materials and methods: From September to December 2008 a total of 30 patients programmed for ESWL with a single, radiopaque kidney or renal pelvic stone not larger than 20 mm in diameter, with or without double-J catheter, were included in the study. They were re-evaluated as out-patients 2 and 3 months after lithotripsy by means of simple abdominal X-ray, analyzing calculus-free state as the total absence of stones at the kidney and renal pelvic level. There were successful results in 7 of the 15 patients (46.6%) of the tamsulosin group and in 5 of the 15 patients (33.3%) in the group receiving standard treatment. Analysis with Student t test and Levene’s test was not statistically significant (P=0.473). It was therefore concluded that tamsulosin, as adjuvant treatment following ESWL, offers no additional benefit.


REFERENCES

  1. Medina EM, Mussaret Z, Real de León E, Orozco RS. Prevalencia y factores de riesgo en Yucatán, México, para litiasis urinaria. Salud Publica Mex 2002;44:541-5.

  2. Otero F, Lugo A, Durán A. Las enfermedades renales en el Instituto Mexicano del Seguro Social (1982-1989). Rev Asoc Med Int Mex 11;1995:21-9.

  3. Daudon M. Epidemiology of nephrolithiasis in France. AnnUrol 2005;39(6):209-31.

  4. Traxer O. Tratamiento quirúrgico de la litiasis urinaria. Encycl Med Chir (Editions Scientifiques et Medicales Elsevier, SAS, París), Nephrologie- Urologie, 18-106-A-10, 2003, 24

  5. Castell R, Garduño L, Cruz NE. Estudio descriptivo de litotricia extracorpórea con litotriptor Dyrex Duet (bifocal) en pacientes del Hospital General de México. Rev Mex Urol 2005;65(4):226-32.

  6. Loske AM, Gutiérrez J. Evaluación in vivo de un sistema de enfoque alterno para litotripsia extracorporal electrohidráulica. Rev Mex Urol 2004;64(6):265-71.

  7. Micali S, Grande M, Sighinol MC. Efficacy of expulsive therapy using nifedipine or tamsulosina, both associated with ketoprofene, after shock wave lithotripsy of ureteral stones. Urol Res 2007;35(3):133–7.

  8. Maldonado AM, Castellanos LJ, Enriquez LJ. Estudio comparativo de la eficacia de la tamsulosina vs. nifedipina para la expulsión de litos ureterales de tercio inferior. Rev Mex Urol 2006;66(2):83-7.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Urol. 2010;70